Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Share News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.20
Bid: 35.10
Ask: 35.30
Change: -0.15 (-0.42%)
Spread: 0.20 (0.57%)
Open: 35.35
High: 35.40
Low: 34.40
Prev. Close: 35.35
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Alliance Pharma names Camillo Pane as chair

Mon, 05th Feb 2024 09:07

(Sharecast News) - Consumer healthcare company Alliance Pharma has appointed Camillo Pane to the role of chairman to "lead the company through its next strategic phase", focusing on organic growth through marketing and innovation.

Alliance Pharma said on Monday that Pane will take over as chairman on 19 February following a handover period from outgoing chair Jo LeCouilliard.

The AIM-listed group highlighted that Panillo has over thirty years' of experience in US, European, and Asian public, multinational consumer companies. During his career, Pane has held a number of senior positions at Reckitt Benckiser, where he spent almost 20 years across both global and regional roles. Most recently, he was group CEO of Health & Happiness Group, a global health and nutrition company listed on the Hong Kong Stock Exchange with revenues of around $2.0bn.

Senior independent director Richard Jones said: "On behalf of the Alliance Board and the company I would like to thank Jo for her significant contribution to Alliance over the past five years and wish her well for the future. We look forward to Camillo joining the board as chair and harnessing his wide-ranging consumer healthcare experience to further enhance and develop our group strategy. In the meantime, the board remains focused on creating value for our shareholders by investing in growth whilst carefully managing our cost base."

As of 0905 GMT, Alliance Pharma shares were up 2.30% at 40.05p.

Reporting by Iain Gilbert at Sharecast.com

More News
12 Dec 2019 16:11

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
27 Nov 2019 15:00

Alliance Pharma handing back 'Xonvea' rights to Duchesnay

(Sharecast News) - Alliance Pharma has reached agreement with Duchesnay of Canada to return the UK and EU licensing rights to 'Xonvea', a prescription medicine for the treatment of nausea and vomiting of pregnancy where conservative management has failed, it announced on Wednesday.

Read more
27 Nov 2019 12:33

Alliance Pharma Exits Xonvea Licensing Deal Amid Slow Sales Uptake

Alliance Pharma Exits Xonvea Licensing Deal Amid Slow Sales Uptake

Read more
17 Sep 2019 16:12

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 18 September KingfisherHalf Year ResultsAccesso TechnologyHalf Year Year Year

Read more
10 Jul 2019 16:12

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 11 July Kenmare ResourcesHalf Year ProductionMcBrideTrading GroupFull

Read more
1 Jul 2019 15:35

Alliance Pharma Founder & Former Chief Executive John Dawson Departs

(Alliance News) - Alliance Pharma PLC said on Monday founder & former chief executive John Dawson decided to step down from the board.Dawson, who was a non-executive director at the on

Read more
16 May 2019 17:55

UK Shareholder Meetings Calendar - Next 7 Days

Friday 17 MayRestaurant GroupBank of Georgia GroupCentaur MediaCairn Continental 20

Read more
10 Apr 2019 16:05

Alliance Pharma's 'Xonvea' gets approval in Ireland

(Sharecast News) - Alliance Pharma announced on Wednesday that 'Xonvea' has gained marketing approval in the Republic of Ireland from the country's medicines regulator, the Health Products Regulatory Authority, for the treatment of nausea and vomiting of pregnancy where conservative management has failed.

Read more
10 Apr 2019 12:27

Alliance Pharma Gets Approval For Anti-Nausea Drug Xonvea In Ireland

LONDON (Alliance News) - Alliance Pharma PLC on Wednesday said its Xonvea drug has been approved in Ireland to treat nausea and vomiting of pregnancy.The Irish marketing approval is first

Read more
26 Mar 2019 11:33

Alliance Pharma Raises Annual Dividend Amid Strong Revenue Growth

LONDON (Alliance News) - Alliance Pharma on Tuesday raised its dividend for 2018 amid a strong revenue performance, though profit fell due to impairments.The pharmaceutical retailer said to

Read more
19 Mar 2019 16:07

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 20 March KingfisherFull Year ResultsCentaur MediaFull Year GroupHalf

Read more
21 Jan 2019 12:42

Alliance Pharma's revenues climb as 'star' products shine

(Sharecast News) - Alliance Pharma on Monday reported a jump in revenue after a strong performance from its 'star' products and newly acquired Nizoral brand.

Read more
14 Jan 2019 15:59

UK Earnings, Trading Statements Calendar - Next 7 Days

Tuesday 15 January Boohoo GroupTrading Statement Gym GroupTrading Workshop Year Year

Read more
2 Oct 2018 09:56

Alliance Pharma launches Xonvea in the UK

(Sharecast News) - Alliance Pharma launched its prescription product for the treatment of nausea and vomiting of pregnancy across the UK on Tuesday.

Read more
1 Oct 2018 13:02

Strategic Equity Capital Underperforms Against Benchmark In Year

LONDON (Alliance News) - Strategic Equity Capital PLC said on Monday it underperformed against its benchmark for its recently ended financial year, due to an undervalued portfolio.The said

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.